Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | nmda type glutamate receptor | 0.0026 | 0.1163 | 0.1194 |
Brugia malayi | POT family protein | 0.004 | 0.2249 | 0.5 |
Mycobacterium tuberculosis | Probable glutamine-binding lipoprotein GlnH (GLNBP) | 0.0019 | 0.0596 | 1 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | 0.0089 | 0.6088 | 1 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein (hisJ) | 0.0019 | 0.0596 | 0.5 |
Chlamydia trachomatis | glutamine binding protein | 0.0019 | 0.0596 | 0.5 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0135 | 0.9741 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0026 | 0.1163 | 0.1194 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0019 | 0.0596 | 0.5 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0026 | 0.1163 | 1 |
Mycobacterium ulcerans | glutamine-binding lipoprotein GlnH | 0.0019 | 0.0596 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.6346 | 0.5286 |
Loa Loa (eye worm) | hypothetical protein | 0.0126 | 0.9035 | 0.8755 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein | 0.0019 | 0.0596 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 355 nM | Transrepression activity at glucocorticoid receptor alpha in IL-1beta-stimulated human A549 cells assessed as inhibition of NFkappaB-dependent E-selectin transcription by luciferase reporter gene assay | ChEMBL. | 21899328 |
EC50 (binding) | = 4360 nM | Transactivation activity at GR-alpha in human NP1 Hela cells assessed as inhibition of GAL4-DBD after 20 hrs by luciferase reporter gene assay | ChEMBL. | 21899328 |
EC50 (binding) | > 5000 nM | Transactivation activity at glucocorticoid receptor alpha human 13D3/Huh7 cells assessed as induction of TAT activity after 4 hrs by spectrophotometry | ChEMBL. | 21899328 |
EC50 (binding) | > 10000 nM | Transactivation activity at GR-alpha in human NP1 Hela cells assessed as induction of GAL4-DBD after 20 hrs by luciferase reporter gene assay | ChEMBL. | 21899328 |
EC50 (binding) | > 10000 nM | Transrepression activity at glucocorticoid receptor alpha in phorbol myristate acetate-stimulated human A549 cells assessed as inhibition of AP1 response element by luciferase reporter gene assay | ChEMBL. | 21899328 |
Emax (binding) | = 0.6 % | Transactivation activity at GR-alpha in human NP1 Hela cells assessed as induction of GAL4-DBD after 20 hrs by luciferase reporter gene assay relative to Dexamethasone | ChEMBL. | 21899328 |
Emax (binding) | = 2 % | Transactivation activity at glucocorticoid receptor alpha human 13D3/Huh7 cells assessed as induction of TAT activity after 4 hrs by spectrophotometry relative to Dexamethasone | ChEMBL. | 21899328 |
Emax (binding) | = 21 % | Transrepression activity at glucocorticoid receptor alpha in IL-1beta-stimulated human A549 cells assessed as inhibition of NFkappaB-dependent E-selectin transcription by luciferase reporter gene assay relative to Dexamethasone | ChEMBL. | 21899328 |
Imax (binding) | = 93 % | Transactivation activity at GR-alpha in human NP1 Hela cells assessed as inhibition of GAL4-DBD after 20 hrs by luciferase reporter gene assay in presence of 100 nM Dexamethasone | ChEMBL. | 21899328 |
Ki (binding) | = 49.5 nM | Displacement of GS-red from glucocorticoid receptor by fluorescence polarization assay | ChEMBL. | 21899328 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.